Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000263072

Medchemexpress LLC Oncrasin-72 | 92407-90-4 | 97.6% | 271.74 | C16H14ClNO | 5 MG
SDP

Catalog No. 5000263072
Encompass_Preferred

Oncrasin-72 is a synthetic small-molecule research compound reported to inhibit RNA polymerase II and to induce cell death in susceptible human cancer cell lines. It is offered in milligram-scale quantities for laboratory use and is characterized by its published chemical identifiers and analytical purity.

  • Provides well-characterized small-molecule activity for mechanistic studies.
  • High chemical purity suitable for in vitro research applications.
  • Available in multiple milligram pack sizes for flexible dosing.
  • Appropriate for cellular assays and transcriptional regulation studies.
  • Documented chemical identifiers simplify database referencing.

Catalog No. 50-002-63072 Supplier Medchemexpress LLC Supplier No. HY1302075MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Oncrasin-72 is a synthetic small-molecule research compound reported to inhibit RNA polymerase II and to induce cell death in susceptible human cancer cell lines. It is offered in milligram-scale quantities for laboratory use and is characterized by its published chemical identifiers and analytical purity.

  • Provides well-characterized small-molecule activity for mechanistic studies.
  • High chemical purity suitable for in vitro research applications.
  • Available in multiple milligram pack sizes for flexible dosing.
  • Appropriate for cellular assays and transcriptional regulation studies.
  • Documented chemical identifiers simplify database referencing.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.